Literature DB >> 11585622

T-cell-based immunity counteracts the potential toxicity of glutamate in the central nervous system.

H Schori1, E Yoles, M Schwartz.   

Abstract

Injuries to the central nervous system (CNS) evoke self-destructive processes, which eventually lead to a much greater loss of tissue than that caused by the trauma itself. The agents of self-destruction include physiological compounds, such as glutamate, which are essential for the proper functioning of the CNS, but become cytotoxic when their normal concentrations are exceeded. The CNS is equipped with buffering mechanisms that are specific for each compound. Here we show, using Balb/c mice (a strain resistant to induction of experimental autoimmune encephalomyelitis), that after intravitreal injection of any concentration of glutamate (a neurotransmitter that becomes toxic when in excess) or ammonium-ferrous sulfate hexahydrate (which increases the formation of toxic oxygen species), the loss of retinal ganglion cells in mice devoid of mature T cells (nude mice) is significantly greater than in matched wild-type controls. We further show that this outcome can be partially reversed by supplying the T cell-defective mice with splenocytes derived from the wild-type mice. The results suggest that potentially toxic physiological compounds, when present in excessive amounts, can recruit and activate a T-cell-dependent self-protective immune mechanism. This may represent a prototype mechanism for the physiological regulation of potentially destructive CNS events by T-cell-mediated immune activity, when the local buffering mechanisms cannot adequately cope with them.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585622     DOI: 10.1016/s0165-5728(01)00358-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  16 in total

Review 1.  Autoimmunity as the body's defense mechanism against the enemy within: Development of therapeutic vaccines for neurodegenerative disorders.

Authors:  Michal Schwartz
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

2.  Histone Deacetylases Contribute to Excitotoxicity-Triggered Degeneration of Retinal Ganglion Cells In Vivo.

Authors:  Annabelle Schlüter; Bahar Aksan; Rossella Fioravanti; Sergio Valente; Antonello Mai; Daniela Mauceri
Journal:  Mol Neurobiol       Date:  2019-06-03       Impact factor: 5.590

3.  Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease.

Authors:  E Hauben; E Agranov; A Gothilf; U Nevo; A Cohen; I Smirnov; L Steinman; M Schwartz
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 4.  Harnessing the immune system for neuroprotection: therapeutic vaccines for acute and chronic neurodegenerative disorders.

Authors:  M Schwartz
Journal:  Cell Mol Neurobiol       Date:  2001-12       Impact factor: 5.046

5.  Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: a dialogue with microglia.

Authors:  Jonathan Kipnis; Hila Avidan; Rachel R Caspi; Michal Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-26       Impact factor: 11.205

6.  Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration.

Authors:  Jonathan Kipnis; Michal Cardon; Hila Avidan; Gil M Lewitus; Sharon Mordechay; Asya Rolls; Yael Shani; Michal Schwartz
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

7.  Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice.

Authors:  Ravid Shechter; Anat London; Chen Varol; Catarina Raposo; Melania Cusimano; Gili Yovel; Asya Rolls; Matthias Mack; Stefano Pluchino; Gianvito Martino; Steffen Jung; Michal Schwartz
Journal:  PLoS Med       Date:  2009-07-28       Impact factor: 11.069

8.  T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions.

Authors:  Jonathan Kipnis; Hagit Cohen; Michal Cardon; Yaniv Ziv; Michal Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-12       Impact factor: 11.205

9.  Immune maintenance in glaucoma: boosting the body's own neuroprotective potential.

Authors:  Michal Schwartz; Anat London
Journal:  J Ocul Biol Dis Infor       Date:  2009-07-21

10.  The privileged immunity of immune privileged organs: the case of the eye.

Authors:  Inbal Benhar; Anat London; Michal Schwartz
Journal:  Front Immunol       Date:  2012-09-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.